MARIA DEL CARMEN
OVEJERO BENITO
INVEST DOCT JUNIOR PROMETEO
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (23)
2023
-
DNA Methylation Description of Hippocampus, Cortex, Amygdala, and Blood of Drug-Resistant Temporal Lobe Epilepsy
Molecular Neurobiology, Vol. 60, Núm. 4, pp. 2070-2085
-
Neuronal and astrocytic tetraploidy is increased in drug-resistant epilepsy
Neuropathology and Applied Neurobiology, Vol. 49, Núm. 1
2022
-
Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
Journal of Personalized Medicine, Vol. 12, Núm. 5
2021
-
ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics
Biomedicine and Pharmacotherapy, Vol. 142
-
Benefits of the application of heat and pressure on peripheral venous cannulation in adults: A randomized controlled trial
Journal of Advanced Nursing, Vol. 77, Núm. 3, pp. 1533-1545
-
DNA copy number variation associated with anti-tumour necrosis factor drug response and paradoxical psoriasiform reactions in patients with moderate-to-severe psoriasis
Acta Dermato-Venereologica
-
Epigenetics in Non-tumor Immune-Mediated Skin Diseases
Molecular Diagnosis and Therapy, Vol. 25, Núm. 2, pp. 137-161
-
Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis
Scientific Reports, Vol. 11, Núm. 1
-
Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder
Neuroscience Letters, Vol. 765
-
Methylation in psoriasis. Does sex matter?
Journal of the European Academy of Dermatology and Venereology
-
Pharmacokinetic variability of eslicarbazepine in real clinical practice
Epilepsy and Behavior, Vol. 124
2020
-
Genome-wide association analysis of psoriasis patients treated with anti-TNF drugs
Experimental Dermatology, Vol. 29, Núm. 12, pp. 1225-1232
-
Pharmacogenetics update on biologic therapy in psoriasis
Medicina (Lithuania), Vol. 56, Núm. 12, pp. 1-15
-
Polymorphisms associated with optimization of biological therapy through drug dose reduction in moderate-to-severe psoriasis
Journal of the European Academy of Dermatology and Venereology
2019
-
Polymorphisms associated with anti-TNF drugs response in patients with psoriasis and psoriatic arthritis
Journal of the European Academy of Dermatology and Venereology
2018
-
Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers
Basic and Clinical Pharmacology and Toxicology, Vol. 122, Núm. 5, pp. 501-511
-
Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis
British Journal of Dermatology
-
Histone modifications associated with biological drug response in moderate-to-severe psoriasis
Experimental Dermatology, Vol. 27, Núm. 12, pp. 1361-1371
-
How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?
Pharmacogenomics, Vol. 19, Núm. 16, pp. 1285-1297
-
Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
American Journal of Clinical Dermatology, Vol. 19, Núm. 2, pp. 209-222